Drug for reducing side effects in ribavirin / interferon...

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 31/232 (2006.01) A61K 31/7056 (2006.01) A61K 38/21 (2006.01) A61P 1/16 (2006.01) A61P 7/06 (2006.01) A61P 31/12 (2006.01) A61P 43/00 (2006.01)

Patent

CA 2516333

There is provided a drug for reducing side effects, anemia in particular, in combination therapy of chronic hepatitis C with ribavirin and interferon, which contains as the active ingredient at least one member selected from the group consisting of eicosapentaenoic acid (EPA) and pharmaceutically acceptable salts and esters thereof.

L'invention concerne un médicament pour atténuer les effets secondaires (et notamment l'anémie) dans la thérapie combinée d'interféron ribaverine dirigée contre l'hépatite C, qui contient en tant qu'ingrédient actif au moins un élément sélectionné dans le groupe constitué d'acide eicosapenténoïque (EPA) et de leurs sels et esters pharmaceutiquement acceptables.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Drug for reducing side effects in ribavirin / interferon... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Drug for reducing side effects in ribavirin / interferon..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Drug for reducing side effects in ribavirin / interferon... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1704283

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.